鼻咽癌治疗新进展

被引：49

作者：

刘孟忠

机构：

[1] 中山大学肿瘤防治中心放射治疗科,华南肿瘤学目录重点实验室

来源：

广东医学 | 2014年 / 35卷 / 01期

关键词：

D O I：

10.13820/j.cnki.gdyx.2014.01.001

中图分类号：

R739.63 [咽肿瘤];

学科分类号：

100213 [耳鼻咽喉科学];

摘要：

<正>鼻咽癌是我国,尤其是华南地区常见肿瘤之一,其病因学、流行病学[1]、临床特征和治疗策略[2]明显有别于其他头颈部肿瘤。近年来,放疗技术的进步和综合治疗的进展使鼻咽癌疗效有所提高。1调强放疗(IMRT)由二维常规放疗(2DCRT)和三维适形放疗进步到IMRT,是放疗技术崭新的里程碑。美国率先报道使用IMRT治疗67例鼻咽癌,4年总生存率(OS)、局部区域无复发率(LRFS)和无远处转移生存率(DMFS)分别为88%、97%和66%[3]。随后的研究结果显示,3年OS和LRFS都大于90%,3年无远处转移

引用

页码：1 / 4

页数：4

共 12 条

[1]

Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities [J].

Sun, Xueming ;

Su, Shengfa ;

Chen, Chunyan ;

Han, Fei ;

Zhao, Chong ;

Xiao, Weiwei ;

Deng, Xiaowu ;

Huang, Shaomin ;

Lin, Chengguang ;

Lu, Taixiang .

RADIOTHERAPY AND ONCOLOGY, 2014, 110 (03) :398-403

[2]

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma [J].

Peng, Gang ;

Wang, Tao ;

Yang, Kun-yu ;

Zhang, Sheng ;

Zhang, Tao ;

Li, Qin ;

Han, Jun ;

Wu, Gang .

RADIOTHERAPY AND ONCOLOGY, 2012, 104 (03) :286-293

[3]

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial [J].

Chen, Lei ;

Hu, Chao-Su ;

Chen, Xiao-Zhong ;

Hu, Guo-Qing ;

Cheng, Zhi-Bin ;

Sun, Yan ;

Li, Wei-Xiong ;

Chen, Yuan-Yuan ;

Xie, Fang-Yun ;

Liang, Shao-Bo ;

Chen, Yong ;

Xu, Ting-Ting ;

Li, Bin ;

Long, Guo-Xian ;

Wang, Si-Yang ;

Zheng, Bao-Min ;

Guo, Ying ;

Sun, Ying ;

Mao, Yan-Ping ;

Tang, Ling-Long ;

Chen, Yu-Ming ;

Liu, Meng-Zhong ;

Ma, Jun .

LANCET ONCOLOGY, 2012, 13 (02) :163-171

[4]

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial [J].

Lee, Nancy Y. ;

Zhang, Qiang ;

Pfister, David G. ;

Kim, John ;

Garden, Adam S. ;

Mechalakos, James ;

Hu, Kenneth ;

Le, Quynh T. ;

Colevas, A. Dimitrios ;

Glisson, Bonnie S. ;

Chan, Anthony T. C. ;

Ang, K. Kian .

LANCET ONCOLOGY, 2012, 13 (02) :172-180

[5]

TREATMENT OF NASOPHARYNGEAL CARCINOMA USING INTENSITY-MODULATED RADIOTHERAPY-THE NATIONAL CANCER CENTRE SINGAPORE EXPERIENCE [J].

Tham, Ivan Weng-Keong ;

Hee, Siew Wan ;

Yeo, Richard Mfng-Chert ;

Salleh, Patemah Bte ;

Lee, James ;

Tan, Terence Wee-Kiat ;

Fong, Kam Weng ;

Chua, Eu Tiong ;

Wee, Joseph Tien-Seng .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (05) :1481-1486

[6]

Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China [J].

Chen, Yong ;

Liu, Meng-Zhong ;

Liang, Shao-Bo ;

Zong, Jing-Feng ;

Mao, Yan-Ping ;

Tang, Ling-Long ;

Guo, Ying ;

Lin, Ai-Hua ;

Zeng, Xiang-Fa ;

Ma, Jun .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (05) :1356-1364

[7]

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial [J].

Pow, Edmond H. N. ;

Kwong, Dora L. W. ;

McMillan, Anne S. ;

Wong, May C. M. ;

Sham, Jonathan S. T. ;

Leung, Lucullus H. T. ;

Leung, Wai Keung .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04) :981-991

[8]

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients [J].

Chi, KH ;

Chang, YC ;

Guo, WY ;

Leung, MJ ;

Shiau, CY ;

Chen, SY ;

Wang, LW ;

Lai, YL ;

Hsu, MM ;

Lian, SL ;

Chang, CH ;

Liu, TW ;

Chin, YH ;

Yen, SH ;

Perng, CH ;

Chen, KY .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (05) :1238-1244

[9]

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience [J].

Lee, N ;

Xia, P ;

Quivey, JM ;

Sultanem, K ;

Poon, I ;

Akazawa, C ;

Akazawa, PM ;

Weinberg, V ;

Fu, KK .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 53 (01) :12-22

[10]

Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin; epirubicin; bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2; M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival.[J]..International Journal of Radiation Oncology; Biol.1996, 3

← 1 2 →